247 related articles for article (PubMed ID: 22267082)
1. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
[TBL] [Abstract][Full Text] [Related]
2. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
[TBL] [Abstract][Full Text] [Related]
5. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
[TBL] [Abstract][Full Text] [Related]
6. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
7. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of ADAM12 in human bladder cancer.
Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM
Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408
[TBL] [Abstract][Full Text] [Related]
9. Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancer.
Yokota S; Ogawara K; Kimura R; Shimizu F; Baba T; Minakawa Y; Higo M; Kasamatsu A; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Int J Oncol; 2013 Dec; 43(6):1864-70. PubMed ID: 24064921
[TBL] [Abstract][Full Text] [Related]
10. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
11. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
Ni ZY; Lin FO; Liu DF; Xiao J
Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
[TBL] [Abstract][Full Text] [Related]
12. [Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues].
Lü XZ; Zou YG; Yin XM; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1362-4. PubMed ID: 18753061
[TBL] [Abstract][Full Text] [Related]
13. ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin.
Jones AV; Lambert DW; Speight PM; Whawell SA
FEBS Lett; 2013 Nov; 587(21):3529-34. PubMed ID: 24055471
[TBL] [Abstract][Full Text] [Related]
14. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
16. Targeting Aurora kinase A suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo.
Tanaka H; Nakashiro K; Iwamoto K; Tokuzen N; Fujita Y; Shirakawa R; Oka R; Goda H; Hamakawa H
Oral Oncol; 2013 Jun; 49(6):551-9. PubMed ID: 23481312
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways.
Kornberg LJ; Villaret D; Popp M; Lui L; McLaren R; Brown H; Cohen D; Yun J; McFadden M
Laryngoscope; 2005 Apr; 115(4):690-8. PubMed ID: 15805883
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
